IQWiG's Rejection Of Merz Alzheimer's Drug Highlights HTA Divergence In The EU
This article was originally published in The Pink Sheet Daily
Executive Summary
German review also leaves open the possibility that a better presentation of the data might make memantine's benefits more obvious.